(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in The Lancet Regional Health: Europe. Peter Nordström, M.D., Ph.D., from Umeå University…
Read MoreBooster COVID-19 shot likely for all Italians in 2022 – health adviser to paper
FILE PHOTO: A health worker administers the third dose of a coronavirus disease (COVID-19) vaccine to a patient deemed to be ‘fragile’, as vaccinations jump in Italy after the government made inoculation mandatory for all workers, in Rome, Italy, September…
Read More